Company news

Inoviq Ltd news in 2024

Inoviq Ltd's news releases, calls and decks from 2024, newest first.

View company

Weaponising Exosomes for Breast Cancer treatment

December 15, 2024

Disease Specificity study completed for NeuCA15-3 test

December 4, 2024

EXO-OC test delivers outstanding performance

December 2, 2024

AGM CEO Presentation

November 27, 2024

INOVIQ receives $1m RDTI refund

November 25, 2024

Quarterly Business Update and Appendix 4C - September 2024

October 30, 2024

NEURO-NET validated in Parkinson's

August 19, 2024

Quarterly Activities Report and Appendix 4C - June 2024

July 29, 2024

Successful completion of Share Purchase Plan

July 4, 2024

INOVIQ lodges SPP and Options Prospectus

June 18, 2024

INOVIQ isolates brain-derived exosomes in Alzheimer's

June 12, 2024

INOVIQ completes $7m placement

June 12, 2024

Breakthrough Exosome Therapy

June 2, 2024

Quarterly Activities Report and Appendix 4C - March 2024

April 30, 2024

Ovarian Cancer Test Validation

April 18, 2024

INOVIQ Investor Update

April 17, 2024

INOVIQ and Promega sign Global EXO-NET Agreement

April 15, 2024

Appendix 4D and FY24 Half Year Financial Report

February 22, 2024

INOVIQ detects 19% more breast cancers than leading test

February 22, 2024

Appendix 4C and Quarterly Activities Report - December 2023

January 30, 2024

Decks in 2024